Navigation Links
Advancing Interoperability - Nonin(R) Medical Unveils World's First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
Date:4/8/2008

MINNEAPOLIS, April 8, 2008 /PRNewswire/ -- Nonin Medical, Inc., in an effort to address rising healthcare costs and promote the use of remote monitoring, unveiled the world's first fingertip oximeter with Bluetooth wireless technology at the American Telemedicine Association (ATA) meeting in Seattle, WA. The revolutionary Onyx(R) II, Model 9560 fingertip pulse oximeter is designed for interoperability, meeting the requirements of the emerging Medical Device Profile (MDP), IEEE11073 and Continua compliance standards. With this innovation, Nonin Medical's commitment is to simplify healthcare delivery by providing innovative solutions that enable patients, such as those with chronic conditions, and clinicians to easily and cost-effectively manage monitored information.

One area of healthcare that stands to benefit greatly from wireless physiological monitoring devices is chronic disease management. Breakthrough devices such as the Onyx II, Model 9560 will enable patients and healthcare professionals alike. Patients who suffer from diseases such as Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF) or Asthma will be able to regain independence -- living healthier lives. The environment where vital signs can be easily monitored by the patient and sent wirelessly through communication devices (cell phones, PDAs, PCs, etc.) creates freedom like never before.

"With the rapidly rising cost of healthcare and the ever-growing strain put on healthcare facilities, there is tremendous pressure for a streamlined solution that simplifies the exchange of information and promotes patient participation," said Gary Tschautscher, President and C.E.O. of Nonin Medical. "The integration of interoperable, Bluetooth wireless technology in health monitoring devices will provide patients and clinicians the ability to monitor vital signs with much greater ease and flexibility."

Since its release in 1995, Onyx(R) has become the most trusted name in fingertip pulse oximetry because of its ease-of-use, extreme durability and precision accuracy. The Onyx II, Model 9560 provides superior accuracy and versatility with its unique SmartPoint(TM) technology and Store and Forward capabilities. To learn more about how to interface with the Onyx II, Model 9560, go to http://www.nonin.com.

About Nonin Medical, Inc. -- http://www.nonin.com

Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health and professionals in more than 125 countries and have over 90 OEM partners worldwide. Nonin's industry-leading capabilities in signal processing and sensor design, plus its on-going integration of features not available in competitive products, are the foundation of its leadership in innovation.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Home Healthcare Reimbursement Freeze is Barrier to Commonwealth Goal of Advancing Alternative Care
2. Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the Tour of Champions
3. Nonin Medical, Inc. Is Recognized for Its Role in Promoting Interoperability
4. Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase
5. Global Interoperability and Patient Privacy Focus of New Liberty Alliance Health Identity Management Group
6. Accenx Technologies Brings Healthcare IT Solutions to HIMSS08 Interoperability Showcase
7. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
8. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
9. Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers Compensation eBilling Solutions
10. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
11. Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGISTS GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Medicine will have the unique opportunity to get hands-on experience in an ... school students an immersive experience to gain invaluable, real-life medical skills that are ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... drug in their bodies, a researcher at the Icahn School of Medicine at ... , The study found that when young children are exposed to secondhand marijuana ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... a women growing up with a schizophrenic mother in a unique, personal perspective ... who specializes in treating trauma and addictive disorders at her private psychotherapy practice. ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to ... analyzed data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical ... the need to operate in a GLP (Good Laboratory Practice) fashion. , With features ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein ... according to a study appearing online in the journal Radiology. , Heart disease and ... increase significantly due to the rapidly aging population. Damage to both organs often occurs ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... The global chromatography market to grow at a CAGR of 5.42% during ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... 2016 According to a ... Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type ... Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast ... witnessed healthy growth during the last decade, and ... 4.3% between 2016 and 2021 to reach USD ...
(Date:12/8/2016)... SAN FRANCISCO, Calif. , Dec. 8, 2016 ... nuclease technology to develop novel antiviral therapeutics, today ... M.D., as chief executive officer and a member ... is an incredibly experienced executive with a deep ... said Stephen Quake, D.Phil., founder of Agenovir, co-president ...
Breaking Medicine Technology: